RFA plus immune stimulation during liver surgery for colon cancer spread
Part of Cancer clinical trials.
This trial looks at whether using a heat-based treatment (RFA) to trigger the immune system before or during liver surgery can improve outcomes for people with colon cancer that has spread to the liver. It’s aimed at people who plan to have the liver tumors removed because they look treatable.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have colon cancer that has spread to the liver (liver metastases) and you plan surgery to remove it
- At least one liver tumor is 3 cm or larger (about the size of a large grape)
- Your overall daily function is very good (performance status 0–1)
- You do not have cirrhosis (serious scarring of the liver)
- Your cancer spread is limited to the liver in a way that can be treated with a curative plan (no untreatable spread outside the liver)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a targeted liver radiation procedure that uses tiny radioactive beads to treat colon cancer spread mostly in the liver. It may help people whose liver tumors cannot be removed or treated with other common local treatments, but it has several safety and “screening” checks.
This trial tests two procedures—irreversible electroporation and stereotactic body radiotherapy—for people whose colorectal cancer has spread to the liver (1–3 tumors near major blood vessels or bile ducts) and can't be surgically removed or treated with heat. The goal is to see if these approaches can safely destroy those hard-to-reach tumors.
This trial tests a combination of treatments for people with colorectal cancer that has spread to the liver and cannot be removed by surgery. It uses an oncolytic virus (which infects and kills cancer cells) along with radiation, chemotherapy, targeted therapy, and immunotherapy to try to shrink the liver tumors.
This trial tests a treatment to boost the immune system after a procedure called radiofrequency ablation (RFA) that uses heat to destroy liver tumors. It is for people with colorectal cancer that has spread to the liver but not elsewhere, and aims to see if this can improve outcomes.
This trial is testing whether a procedure called radiofrequency ablation (using heat to destroy tumors) is safe and effective for people whose colorectal cancer has spread to the liver and come back there. It might help if you have a few small liver tumors that cannot be removed with surgery.
This study looks at whether using radiofrequency (a heat-based treatment used during surgery) during liver surgery can lower the chances that cancer returns locally. It includes people with colorectal cancer that has spread to the liver and people with liver cancer (HCC).
Hear when a new Liver Metastasis Colon Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.